Full Text View
Tabular View
No Study Results Posted
Related Studies
Attenuation of Cardiac Effects of Arteriovenous Fistula Creation With Losartan
The recruitment status of this study is unknown because the information has not been verified recently.
Verified June 2006 by Melbourne Health.
Recruitment status was  Recruiting
Study NCT00602004   Information provided by Melbourne Health

First Received on March 8, 2007.   Last Updated on January 15, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Renal Failure
Left Ventricular Hypertrophy
Additional conditions recognized in this trial
Arteriovenous Fistula
Hypertrophy
Hypertrophy, Left Ventricular
Renal Insufficiency
More general conditions related to this trial
Arteriovenous Malformations
Cardiomegaly
Cardiovascular Abnormalities
Cardiovascular Diseases
Congenital Abnormalities
Fistula
Heart Diseases
Kidney Diseases
Pathological Conditions, Anatomical
Urologic Diseases
Vascular Diseases
Vascular Fistula
Vascular Malformations
Interventions listed in this trial
losartan
More general drug interventions related to this trial
Angiotensin II Type 1 Receptor Blockers
Angiotensin Receptor Antagonists
Anti-Arrhythmia Agents
Antihypertensive Agents
Cardiovascular Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Melbourne Health


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services